Literature DB >> 5405509

[Behavior of the ECG in normal, reserpinized or emetinized rats previously perfused with various beta-adrenolytic agents].

E Marmo.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5405509

Source DB:  PubMed          Journal:  Arch Kreislaufforsch        ISSN: 0003-9217


× No keyword cloud information.
  7 in total

1.  Protective drugs in emetine poisoning.

Authors:  A MARINO
Journal:  Chemotherapia (Basel)       Date:  1962

2.  Accumulation of norepinephrine in rat tissue following treatment with three beta-adrenergic antagonists.

Authors:  T C Westfall
Journal:  Arch Int Pharmacodyn Ther       Date:  1967-05

3.  Enhancement of peripheral alpha-receptor stimulation by blockade of "silent" beta receptors.

Authors:  T F Burks; T Cooper
Journal:  Circ Res       Date:  1967-11       Impact factor: 17.367

4.  Action of a beta adrenergic receptor blocking agent on the positive chronotropic response and uptake of norepinephrine in the perfused guinea-pig heart.

Authors:  T C Westfall
Journal:  J Pharmacol Exp Ther       Date:  1968-08       Impact factor: 4.030

5.  Effect of beta adrenergic blocking agents on the noradrenaline content of rat heart before and after noradrenaline infusion.

Authors:  T C Westfall
Journal:  Eur J Pharmacol       Date:  1967-12       Impact factor: 4.432

6.  Inhibition of sympathomimetic effects on the cardiovascular system by 4-(2-isopropylamino-1-hydroxyethyl)methanesulfonanilide hydrochloride (MJ 1999).

Authors:  P Aramendía; A J Kaumann
Journal:  J Pharmacol Exp Ther       Date:  1967-02       Impact factor: 4.030

7.  The effects of some beta-adrenoreceptor blocking drugs on the uptake and release of noradrenaline by the heart.

Authors:  J W Foo; A Jowett; A Stafford
Journal:  Br J Pharmacol       Date:  1968-09       Impact factor: 8.739

  7 in total
  1 in total

Review 1.  Duchenne muscular dystrophy.

Authors:  Dongsheng Duan; Nathalie Goemans; Shin'ichi Takeda; Eugenio Mercuri; Annemieke Aartsma-Rus
Journal:  Nat Rev Dis Primers       Date:  2021-02-18       Impact factor: 52.329

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.